“…Though some studies have validated the antibacterial potential of C‐terminal region of Asp49 PLA 2 s (Costa et al, ), multiple studies have been carried out on Lys49 PLA 2 s, due to the independence of catalytic activity suggesting the presence of noncatalytic molecular regions capable of exerting different bioactivities. In this connection, Lomonte, Moreno, Tarkowski, Hanson, and Maccarana () demonstrated for the first time that biomimetic peptides replicate the effects of their parent svPLA 2 s. Since this pioneering study, many synthetic peptides based on the same molecular regions were evaluated for a better understanding of the mechanisms of myotoxic, antibacterial, antiviral, and antitumoral actions of Lys49 svPLA 2 s (Almeida et al, ; Gebrim et al, ; Lomonte et al, ). Therefore, these catalytically inactive toxins are taken as valuable templates for creation and innovation in antibiotherapy, building on smaller peptide segments with antibacterial potential (Figure ).…”